Stock Events

Stock Events

Allogene Therapeutics (ALLO) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.41

-0.37

-0.32

-0.28

Details

Expected EPS

-0.326522

Actual EPS

-0.28

Surprise EPS

0.05

Surprise Percent

+14.25%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.28 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.